Affordable Innovation
| Name | Indication | Clinical Trial Phase | Study Title |
|---|---|---|---|
| HLX07 |
Advanced Soild Tumours
|
Phase I | An Open-label, Phase I Study to Determine the Maximum Tolerated Dose of HLX07,in Patients with Advanced Solid Cancers |
| HLX04 |
Healthy Male Subjects
|
Phase I |
Pharmacokinetic, Safety and Immunogenicity Similarity Study of HLX04 Versus Avastin® |
| HLX04 |
metastatic Colorectal Cancer (mCRC)
|
Phase III |
A Phase III Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab in the First-line Treatment of mCRC |
| HLX03 |
Healthy Male Subjects
|
Phase I |
A Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of HLX03 and Humira® |
| HLX03 |
Moderate To Severe Plaque Psoriasis
|
Phase III |
Study of Efficacy and Safety of HLX03 in Subjects with Moderate to Severe Plaque Psoriasis |
